Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Clinical trial NCT03295877 · COMPLETED
Trial details
- NCT number
- NCT03295877
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2018-11-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.